The gut-kidney axis plays a crucial role in the pathogenesis of kidney diseases
However, concerns have arisen that their use may be associated with pancreatic and thyroid cancer development [9]
GLP-1 medications also work at the brain level
Drugmaker Eli Lilly (LLY -0.53%) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the first of several phase 3 drug trials
Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Freeze-thaw cycling can disrupt the copper coordination sphere as well as degrade the peptide backbone